NEFL and Alzheimer disease: Therefore, we reasonably anticipate that NFL and GFAP are likely to be significant prognostic predictors in participants with pre-existing AD pathology, primarily because these participants have a high probability of marked fluctuations in neurodegeneration, neuroinflammation, and cognitive function.